CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review Infective Endocarditis After Transcatheter Aortic Valve Replacement New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies

Consensus2009 Apr 28;53(17):1573-619.

JOURNAL:https://www.sciencedirect.com/science/article/pii/ Article Link

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association

McLaughlin VV, Archer SL, Badesch DB et al. Keywords: pulmonary hypertension; consensus

FULL TEXT PDF